Induction of CYP1A by a diterpene quinone tanshinone IIA isolated from a medicinal herb Salvia miltiorrhiza in C57BL/6J but not in DBA/2J mice

被引:44
作者
Ueng, YF
Kuo, YH
Wang, SY
Lin, YL
Chen, CF
机构
[1] Natl Res Inst Chinese Med, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Inst Tradit Med, Taipei 112, Taiwan
关键词
tanshinone IIA; cytochrome P450; B6; mice; D2; liver;
D O I
10.1016/j.lfs.2003.07.035
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Effects of tanshinone IIA, an active diterpene quinone of the herbal medicine Salvia miltiorrhiza (Danshen), on cytochrome P450 (CYP), UDP-glucuronosyl transferase (UGT), and glutathione S-transferase (GST) were studied in the arylhydrocarbon (Ah)-responsive C57BL/6J (B6) and nonresponsive DBA/2J (D2) mice. Oral treatment of tanshinone IIA caused a dose-dependent increase of liver microsomal 7-methoxyresorufin O-demethylation (MROD) activity in B6 but not in D2 mice. In B6 mice, tanshinone IIA increased hepatic benzo(a)pyrene hydroxylation (AHH), 7-ethoxyresorufin O-deethylation, MROD, and 7-ethoxycoumarin O-deethylation activities. The levels of Cyp1A2 protein and mRNA were elevated. On the contrary, in D2 mice, tanshinone IIA decreased hepatic AHH and nifedipme oxidation activities and the CYP3A protein level without affecting other activities determined. Cyp1A2 protein and mRNA levels were not affected by tanshinone IIA in D2 mice. Tanshinone IIA had no effects on UGT and GST activities in both B6 and D2 mice. These results demonstrated that induction of CYP1A2 by tanshinone IIA depended on the Ah-responsiveness and occurred at pre-translational level. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:885 / 896
页数:12
相关论文
共 38 条
  • [1] ALVARES AP, 1970, MOL PHARMACOL, V6, P206
  • [2] OXIDATION OF BENZO[A]PYRENE BY RECOMBINANT HUMAN CYTOCHROME-P450 ENZYMES
    BAUER, E
    GUO, ZY
    UENG, YF
    BELL, LC
    ZELDIN, D
    GUENGERICH, FP
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (01) : 136 - 142
  • [3] UDP-GLUCURONOSYLTRANSFERASE ACTIVITIES - GUIDELINES FOR CONSISTENT INTERIM TERMINOLOGY AND ASSAY CONDITIONS
    BOCK, KW
    BURCHELL, B
    DUTTON, GJ
    HANNINEN, O
    MULDER, GJ
    OWENS, IS
    SIEST, G
    TEPHLY, TR
    [J]. BIOCHEMICAL PHARMACOLOGY, 1983, 32 (06) : 953 - 955
  • [4] Burczynski ME, 2000, CANCER RES, V60, P908
  • [5] Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells
    Cao, EH
    Liu, XQ
    Wang, JJ
    Xu, NF
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (06) : 801 - 806
  • [6] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [7] DENG HJ, 1992, CHINA J CHIN MAT MED, V17, P233
  • [8] Herb-drug interactions
    Fugh-Berman, A
    [J]. LANCET, 2000, 355 (9198) : 134 - 138
  • [9] FUJIIKURIYAMA Y, 1995, PHARMACOGENETICS, V5, P149
  • [10] GELBOIN HV, 1993, PHARMACOL REV, V45, P413